The table below shows Corbus Pharmaceuticals Holdings, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$0.00
$881.71K
$3.94M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$70.09M
$32.22M
$31.17M
$16.14M
$36.45M
$98.27M
SG&A
$15.21M
CRBP annual revenue (10-K history)
Corbus Pharmaceuticals Holdings, Inc. reported annual revenue of $0.00 for fiscal year 2022. That is down 100.0% from $881.71K in fiscal 2021. Over the 8 fiscal years shown, annual revenue declined from $648.38K (FY 2015) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.